Suzanne Nielsen

8.1k total citations · 3 hit papers
254 papers, 5.5k citations indexed

About

Suzanne Nielsen is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Anesthesiology and Pain Medicine. According to data from OpenAlex, Suzanne Nielsen has authored 254 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 207 papers in Public Health, Environmental and Occupational Health, 86 papers in Epidemiology and 82 papers in Anesthesiology and Pain Medicine. Recurrent topics in Suzanne Nielsen's work include Opioid Use Disorder Treatment (200 papers), Pain Management and Opioid Use (82 papers) and Substance Abuse Treatment and Outcomes (72 papers). Suzanne Nielsen is often cited by papers focused on Opioid Use Disorder Treatment (200 papers), Pain Management and Opioid Use (82 papers) and Substance Abuse Treatment and Outcomes (72 papers). Suzanne Nielsen collaborates with scholars based in Australia, United States and United Kingdom. Suzanne Nielsen's co-authors include Louisa Degenhardt, Nicholas Lintzeris, Briony Larance, Gabrielle Campbell, Raimondo Bruno, Wayne Hall, Michael Farrell, Bianca Hoban, Natasa Gisev and Milton Cohen and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Cochrane Database of Systematic Reviews.

In The Last Decade

Suzanne Nielsen

229 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A synthesis of oral morphine equivalents (OME) for opioid utilisation studies

2015 408 citations Suzanne Nielsen, Louisa Degenhardt et al. profile →
Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies

2018 293 citations Emily Stockings, Gabrielle Campbell et al. Pain profile →
The Impact of Stigma on People with Opioid Use Disorder, Opioid Treatment, and Policy

2022 103 citations Louisa Picco, Dan I. Lubman et al. SHILAP Revista de lepidopterología profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Suzanne Nielsen Australia	37	3.3k	1.7k	1.6k	1.4k	929	254	5.5k
William C. Becker United States	36	3.1k 0.9×	1.5k 0.9×	1.5k 0.9×	1.5k 1.1×	1.0k 1.1×	172	5.2k
Nicholas Lintzeris Australia	39	3.1k 0.9×	2.1k 1.2×	2.2k 1.3×	949 0.7×	978 1.1×	214	5.5k
Lawrence Scholl United States	12	3.7k 1.1×	505 0.3×	1.7k 1.0×	1.2k 0.9×	1.1k 1.2×	18	5.0k
Tamara M. Haegerich United States	24	5.9k 1.8×	1.9k 1.2×	1.2k 0.7×	3.9k 2.8×	1.7k 1.9×	35	8.3k
Patrick G. O’Connor United States	48	4.9k 1.5×	1.1k 0.7×	4.8k 2.9×	1.0k 0.7×	1.2k 1.3×	148	9.0k
Mbabazi Kariisa United States	21	3.2k 1.0×	459 0.3×	1.7k 1.1×	885 0.6×	898 1.0×	26	4.9k
Cynthia I. Campbell United States	30	2.3k 0.7×	1.0k 0.6×	1.2k 0.7×	1.3k 0.9×	738 0.8×	138	4.0k
Robert Ali Australia	45	3.5k 1.1×	1.3k 0.8×	4.4k 2.7×	648 0.5×	1.1k 1.2×	183	8.6k
Jodie Trafton United States	40	1.9k 0.6×	1.0k 0.6×	1.1k 0.6×	976 0.7×	456 0.5×	138	7.2k
Briony Larance Australia	29	2.1k 0.6×	656 0.4×	1.1k 0.7×	916 0.7×	518 0.6×	125	2.8k

Countries citing papers authored by Suzanne Nielsen

Since Specialization

Citations

This map shows the geographic impact of Suzanne Nielsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Nielsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Nielsen more than expected).

Fields of papers citing papers by Suzanne Nielsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Nielsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Nielsen. The network helps show where Suzanne Nielsen may publish in the future.

Co-authorship network of co-authors of Suzanne Nielsen

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Nielsen. A scholar is included among the top collaborators of Suzanne Nielsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Nielsen. Suzanne Nielsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jamshidi, Negar, et al.. (2025). Prevalence and risk factors for opioid overdose among women: A systematic review and meta-analysis. Drug and Alcohol Dependence. 273. 112702–112702.

Lam, Tina, Sarah Callinan, Brian Vandenberg, et al.. (2025). Leveraging web-scraped data to examine alcohol pricing: an Australian feasibility study with retail data. International Journal of Drug Policy. 148. 105115–105115.

Nielsen, Suzanne, Rebecca McDonald, Alexander Y. Walley, et al.. (2024). Development of pharmacy-based best practices to support safer use and management of prescription opioids based on an e-Delphi methodology. Research in Social and Administrative Pharmacy. 20(12). 1110–1117.

Newby, David, et al.. (2024). Medication management issues perceived by pharmacists and disability caregivers while supporting people with disability. SHILAP Revista de lepidopterología. 15. 100489–100489.

Xia, Ting, et al.. (2024). Australian community pharmacists’ experiences of prescription drug monitoring programs: Comparisons between mandated and nonmandated states. Journal of the American Pharmacists Association. 65(2). 102313–102313.

Nielsen, Suzanne & Ting Xia. (2024). Interventions for reducing the prescribing of pharmaceutical opioids in Australia: are they effectively reducing opioid harm?. The Medical Journal of Australia. 220(6). 311–312. 1 indexed citations

Xia, Ting, Louisa Picco, Rachelle Buchbinder, Romi Haas, & Suzanne Nielsen. (2024). Association of state‐level prescription drug monitoring program implementation with opioid prescribing transitions in primary care in Australia. British Journal of Clinical Pharmacology. 90(4). 1162–1172. 1 indexed citations

Xia, Ting, et al.. (2024). Predictors of persistent opioid use in Australian primary care: a retrospective cohort study, 2018–2022. Pain Medicine. 25(12). 748–757. 2 indexed citations

Nielsen, Suzanne, et al.. (2024). Experiences of misuse and symptoms of dependence among people who use gabapentinoids: A qualitative systematic review. International Journal of Drug Policy. 133. 104605–104605. 4 indexed citations

10.

Picco, Louisa, et al.. (2023). Identifying Prescription-Opioid-Related Risks Using Prescription Drug Monitoring Programs’ Algorithms and Clinical Screening Tools. SHILAP Revista de lepidopterología. 11(5). 164–164.

11.

Bero, Lisa, Fiona Blyth, Jason N. Doctor, et al.. (2023). Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations. The Medical Journal of Australia. 219(2). 80–89. 25 indexed citations

12.

Sturgiss, Elizabeth, Jenny Advocat, Tina Lam, et al.. (2023). Multifaceted intervention to increase the delivery of alcohol brief interventions in primary care: a mixed-methods process analysis. British Journal of General Practice. 73(735). e778–e788. 3 indexed citations

13.

Roxburgh, Amanda, Michael Livingston, Paul Dietze, et al.. (2023). The impact of COVID-19 public health measures on attendance and overdose at supervised injecting facilities in Australia. Public Health. 224. 90–97.

14.

Nielsen, Suzanne, et al.. (2023). Experiences of misuse and symptoms of dependence among people who use gabapentinoids: a qualitative systematic review protocol. BMJ Open. 13(9). e073770–e073770. 2 indexed citations

15.

Nielsen, Suzanne, Monica J. Barratt, Mark J. Bartlett, et al.. (2023). Monitoring for fentanyl within Australian supervised injecting facilities: Findings from feasibility testing of novel methods and collaborative workshops. International Journal of Drug Policy. 115. 104015–104015. 10 indexed citations

16.

Monds, Lauren A., María Carmen Bravo, Llewellyn Mills, et al.. (2022). The Overdose Response with Take Home Naloxone (ORTHN) project: Evaluation of health worker training, attitudes and perceptions. Drug and Alcohol Review. 41(5). 1085–1094.

17.

Nielsen, Suzanne, et al.. (2021). A prospective cohort study evaluating the impact of upscheduling codeine in Australia among frequent users of codeine. Addiction. 117(3). 677–686. 4 indexed citations

18.

Campbell, Gabrielle, Emily Stockings, & Suzanne Nielsen. (2019). Understanding the evidence for medical cannabis and cannabis-based medicines for the treatment of chronic non-cancer pain. European Archives of Psychiatry and Clinical Neuroscience. 269(1). 135–144. 28 indexed citations

19.

Stockings, Emily, Gabrielle Campbell, Wayne Hall, et al.. (2018). Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies. Pain. 159(10). 1932–1954. 293 indexed citations breakdown →

20.

Peacock, Amy, Louisa Degenhardt, Gabrielle Campbell, et al.. (2016). A Typology of Predictive Risk Factors for Non-Adherent Medication-Related Behaviors among Chronic Non-Cancer Pain Patients Prescribed Opioids: A Cohort Study.. PubMed. 19(3). E421–34. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact